The high-tech facility in Trujillo will strengthen the company’s genetic development capabilities and enable more efficient scaling of growth plans in new crop areas, using state-of-the-art biotechnology for precision propagation
Camposol has inaugurates a new biofactory, described as a high-tech facility that marks a milestone in its strategy of innovation, sustainability, and agricultural expansion.
The modern infrastructure will ”strengthen the company’s genetic development”, it said, and enable it to scale its growth plan in new crop areas more efficiently.
Located on the Camposol premises in Chao, Virú (Trujillo), the biofactory covers an area of 2,000m2 and has an annual production capacity of up to 5mn blueberry plants.
The facility integrates in vitro and ex vitro production processes in the same space, using state-of-the-art biotechnology that ensures precision, consistency, and speed throughout the propagation process, Camposol explained.
”In the in vitro production area, the establishment and multiplication phases are carried out, combining conventional methods with the use of bioreactors, achieving high efficiency in propagation rates and significantly reducing time and resource use,” it stated.
“All steps of the process are carried out through traditional (non-GMO) breeding methods.
”For its part, ex vitro production incorporates European ’growth chamber’ technology, which, through precise control of temperature, humidity, CO2, and specialised lighting, optimises the acclimatisation of seedlings – including rooting, growth, and hardening – before their transfer to the final nursery and, subsequently, to the production fields,” the group added.
The operation is carried out by a highly specialised team with extensive experience in tissue culture and plant biotechnology.
”The inauguration of this biofactory reinforces our commitment to innovation and sustainability,“ said Ricardo Naranjo, CEO of Camposol.
”It gives us a strategic advantage that will allow us to accelerate the development and multiplication of new proprietary varieties, aligned with the preferences of our customers and consumers around the world.”
Thanks to this new biofactory, Camposol said it will be able to scale up its plans to plant new hectares using its own blueberry genetics and replant existing areas with more competitive varieties.
The company also has a ”constantly evolving genetic programme”, which will enable it to develop new varieties year after year, adapted to local conditions and international market demands.
The installed capacity ensures rapid, large-scale production of new seedlings, it said, ”reinforcing its leadership” in productivity, innovation, and sustainability.
“This biofactory is a key tool for our future growth,” confirmed Naranjo. “It gives us independence and the ability to ensure the availability of the plants needed to execute our strategic expansion and consolidation plan.
”With this new infrastructure, we strengthen our position as a solid, innovative agroindustrial company that is prepared to continue growing in a sustainable manner.”
